Stock listing
NASDAQ:IMDZ Immune Design Corp Stock
Follow Immune Design Corp into a list and get an email when it puts out news.
Last close · NASDAQ:IMDZ
$5.85 USD
Close on Apr 1, 2019 · No longer trades
- Lowest – highest close
- $1.15 – $36.19 USDSince Jul 24, 2014 · lowest Dec 21, 2018 · highest Dec 22, 2014
Delisted NASDAQ:IMDZ no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IMDZ
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Franklin Berger Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Five Prime Therapeutics Inc (Director · Jun 10, 2019 – Apr 16, 2021 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past) | Director · Apr 2, 2019 – Apr 2, 2019 · Past |
| Carlos Paya Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 15, 2025); Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Mallinckrodt Inc (Director · May 22, 2019 – Jun 16, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Jun 14, 2023 · Past) | President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past |
| David Baltimore Other companies: Regulus Therapeutics Inc (Director · Since at least Jun 2, 2016); Amgen Inc. (Director · Mar 30, 2016 – Apr 27, 2018 · Past) | Director · Jan 4, 2016 – Apr 2, 2019 · Past |
| Edward Penhoet Other companies: Scynexis, Inc. (Director · May 2, 2014 – Jun 4, 2015 · Past); ChemoCentryx Inc. (Director · Feb 8, 2012 – May 23, 2013 · Past) | Director · Jul 23, 2014 – Apr 2, 2019 · Past |
| James Paul Rickey Other companies: Braveheart Bio, Inc. (Chief Financial Officer · Since at least Aug 5, 2026); Alpine Immune Sciences Inc (See Remarks · Jul 24, 2017 – May 20, 2024 · Past) | VP, Finance and Administration · Jul 23, 2014 – Jan 7, 2015 · Past |
| Richard T Kenney Other companies: Chanticleer Holdings Inc (Chief Medical Officer · Since at least Mar 22, 2021) | Chief Medical Officer · Jul 23, 2014 – Jan 4, 2016 · Past |
Log in to ask 6ix AI your own questions about Immune Design Corp.